Metropolis Healthcare Q2 FY27: revenue up 15.8% to ₹497 Cr, net profit up 42.7% to ₹76 Cr
Results · Finvezto · 3 Nov 2026 · Metropolis Healthcare (METROPOLIS)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 497 | +10.4% | +15.8% |
| Operating profit | 134 | +20.5% | +23.8% |
| Net profit | 76 | +32.7% | +42.7% |
| Operating margin | 27.0% | +2.3 pp | +1.7 pp |
| Net margin | 15.2% | +2.6 pp | +2.9 pp |
Key points
- Metropolis Healthcare reported a 15.8% year-on-year increase in consolidated revenue from operations to Rs 496.8 crore for Q2 FY27, with reported EBITDA rising 23.9% to Rs 134.9 crore and PAT increasing 42.7% to Rs 75.5 crore. NSE filing
- Growth was supported by a 10% rise in patient volume and an 11% increase in test volume, while the board declared an interim dividend of Rs 1 per share. NSE filing
- Revenue was ₹497 Cr, up 15.8% on a year earlier and up 10.4% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 23.4%, 25.4%, 24.7%, 27.0%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 42, 51, 57, 76.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.